Adult-Onset Still's Disease
6 clinical trials · Condition
◉ Watch Adult-Onset Still's Disease
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD (NCT04717635) | Novartis Pharmaceuticals | 2021-03-30 |
| A Study to Evaluate Camoteskimab in Participants With Still's Disease (NCT04752371) | Apollo Therapeutics Ltd | 2021-03-25 |
| Canakinumab for Treatment of Adult-onset Still's Disease (NCT02204293) | Charite University, Berlin, Germany | 2012-06-21 |
| Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study (NCT01033656) | University of Helsinki | 2005-12-01 |
Track Adult-Onset Still's Disease automatically
Every clearance here is in the API, with alerts when new ones post.